The nation of Zimbabwe has turned down a substantial US health deal worth $367m (£272m) spanning five years due to the United States' insistence on sensitive biological samples.
The decision became public after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesperson has since explained that the United States was requesting biological samples for research and profit but was not willing to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further dialogue to find a agreement suitable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development comes after a similar situation in Kenya, where a high court suspended a related health funding agreement after concerns were raised about the security of citizens' medical information.
After returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date signed these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its biological resources and data for a long time, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our country would supply the raw materials for medical research without any assurance that the final treatments would be available to our citizens should a new health crisis arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks already established through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This system is designed to ensure that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that respects the sovereignty and dignity of each country."
Health Experts Response
Medical experts expressed it understood the official position, but recommended that negotiations must proceed considering a large portion of the country's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
This impasse underscores the ongoing tensions between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.